- $569.91m
- $585.48m
- $172.55m
- 81
- 20
- 57
- 52
2019 September 30th | 2020 September 30th | 2021 September 30th | R2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 84.6 | 101 | 120 | 145 | 173 |
Cost of Revenue | |||||
Gross Profit | 72.3 | 88.1 | 105 | 125 | 150 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 89.2 | 92.4 | 107 | 133 | 157 |
Operating Profit | -4.59 | 8.87 | 13.3 | 12.2 | 15.6 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -3.99 | 9.41 | 8.8 | 3.6 | 10.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.724 | 7.81 | 7.98 | 3.69 | 8.03 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -0.724 | 7.81 | 7.98 | 3.69 | 8.03 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.724 | 7.81 | 7.98 | 3.69 | 8.03 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.055 | 0.247 | 0.226 | 0.13 | 0.266 |